Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2C | P18825 | 6/20 | 0.79 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.37 |
| ▸ | TMPRSS15 | P98073 | 2/20 | 0.35 |
| ▸ | MAPK8 | P45983 | 5/20 | 0.35 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.34 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.34 |
| ▸ | ACKR3 | P25106 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29787277 | 1.00 | ADRA2C (0.79) | ADRA2CHRH3TMPRSS15MAPK8ITGB3 | |
| SCHEMBL24183645 | 1.00 | ADRA2C (0.79) | ADRA2CHRH3TMPRSS15MAPK8ITGB3 | |
| SCHEMBL30398367 | 1.00 | ADRA2C (0.79) | ADRA2CHRH3TMPRSS15MAPK8ITGB3 | |
| SCHEMBL29787312 | 1.00 | ADRA2C (0.79) | ADRA2CHRH3TMPRSS15MAPK8ITGB3 | |
| SCHEMBL25437600 | 1.00 | ADRA2C (0.79) | ADRA2CHRH3TMPRSS15MAPK8ITGB3 | |
| SCHEMBL29787323 | 1.00 | ADRA2C (0.79) | ADRA2CHRH3TMPRSS15MAPK8ITGB3 | |
| SCHEMBL24183463 | 0.93 | ADRA2C (0.83) | ADRA2CHRH3TMPRSS15MAPK8ITGB3 | |
| SCHEMBL29787254 | 0.93 | ADRA2C (0.83) | ADRA2CHRH3TMPRSS15MAPK8ITGB3 | |
| SCHEMBL24183636 | 0.91 | ADRA2C (0.74) | ADRA2CHRH3TMPRSS15MAPK8ITGB3 | |
| SCHEMBL29787289 | 0.91 | ADRA2C (0.74) | ADRA2CHRH3TMPRSS15MAPK8ITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023118123-A1 | COMBINATION OF AN Α2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONIST WITH A NOREPINEPHRINE REUPTAKE INHIBITOR FOR THE TREATMENT OF SLEEP APNEA | BAYER AKTIENGESELLSCHAFT (DE) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023118098-A1 | COMBINATION OF AN α2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS WITH A MUSCARINIC RECEPTOR ANTAGONIST FOR THE TREATMENT OF SLEEP APNEA | BAYER AKTIENGESELLSCHAFT (DE) | 2023-06-29 | — | — | WO | disclosed |